價(jià)格 | 詢價(jià) | ||
包裝 | 10mg | 100mg | 1000mg |
最小起訂量 | 10mg |
發(fā)貨地 | 江西 |
更新日期 | 2024-12-26 |
中文名稱:cyclo-(Phe-Arg-Gly-Asp-Leu-Ala-Phe-D-Pro-(NMe)Lys) | 英文名稱:cyclo-(Phe-Arg-Gly-Asp-Leu-Ala-Phe-D-Pro-(NMe)Lys) |
CAS:2089299-82-9 | 品牌: TanzhenBio |
產(chǎn)地: 江西 | 保存條件: -20℃ |
純度規(guī)格: 98% | 產(chǎn)品類別: 多肽 |
是否進(jìn)口: 否 |
Expression of the cellular transmembrane receptor αvβ6 integrin is mostly restricted to malignant epithelial cells in a wide variety of carcinomas, including pancreatic and others derived from epithelial tissues. Thus, this protein is considered an attractive target for tumour imaging and therapy. Two different 68Ga hexadentate tris (3,4-hydroxypyridinone) (THP) chelators were produced in this study and coupled to the αvβ6 integrin–selective peptide cyclo(FRGDLAFp(NMe)K) via NHS chemistry. Radiolabelling experiments confirmed a high radiochemical yield of the two PET probes. In addition, cellular binding studies showed high binding affinities in the nanomolar range. The two integrin αvβ6-peptide-THP synthesized and radiolabeled in this study will facilitate in vivo monitoring of transmembrane receptor αvβ6 integrin by using the advantage of THP chemistry for rapid, efficient and stable gallium chelation.
成立日期 | 2019-02-05 (6年) | 注冊資本 | 300萬人民幣 |
員工人數(shù) | 10-50人 | 年?duì)I業(yè)額 | ¥ 100萬-300萬 |
主營行業(yè) | 生物活性小分子,有機(jī)合成試劑,氨基糖苷類 | 經(jīng)營模式 | 貿(mào)易,工廠,試劑,定制,服務(wù) |
產(chǎn)品名稱 | 價(jià)格 | 公司名稱 | 報(bào)價(jià)日期 | |
---|---|---|---|---|
詢價(jià) |
VIP2年
|
上海拓旸生物科技有限公司
|
2024-08-26 | |
詢價(jià) |
VIP1年
|
寶雞締都醫(yī)藥化工有限公司
|
2024-11-25 | |
詢價(jià) |
VIP2年
|
寶雞締都醫(yī)藥化工有限公司
|
2025-01-10 |